P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Scribed by Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S.; Boyce, A.; Briggs, P.; Horwood, K.; Karapetis, C.

• Book ID: 118573458
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 144 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(05)81047-5